Full year financial results 1 October 2024 - 30 September 2025 Coloplast delivered Q4 organic growth of 7% and an EBIT ...

The market is expanding due to an aging population, rising awareness, and product advancements. Major companies like Essity Aktiebolag, Kimberly-Clark, and others are enhancing product effectiveness ...

Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, ...

The Global Advanced Wound Care Market is poised to grow at a CAGR of 6–8% through 2029, driven by the rising incidence of chronic wounds, traumatic and surgical injuries, and a growing elderly ...

A comprehensive new market study by Credence Research reveals steady and sustained growth for the Global Silver Wound ...

The US market is looking expensive, so investors may be wondering which stocks to buy now against this backdrop. Regardless of where the markets are headed, investors may want to own companies that ...

The global Incontinence Care Products Market is on a steady growth path — estimated at USD 13.5 billion in 2025 and forecast ...

If you thought the European Union’s top export to the U.S. was cars, think again. The EU shipped 120 billion euros ($140 billion) worth of “medicinal and pharmaceutical products” across the Atlantic ...

Coloplast interim CEO Lars Rasmussen has today informed the Coloplast Board of Directors that he will not stand for re-election as board member at the upcoming annual general meeting on December 4, ...